Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Medtronic Inc (MDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 124,271,056
  • Shares Outstanding, K 1,341,151
  • Annual Sales, $ 29,953 M
  • Annual Income, $ 3,104 M
  • 60-Month Beta 0.82
  • Price/Sales 4.11
  • Price/Cash Flow 13.60
  • Price/Book 2.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/19
See More
  • Average Estimate 1.47
  • Number of Estimates 13
  • High Estimate 1.49
  • Low Estimate 1.43
  • Prior Year 1.42
  • Growth Rate Est. (year over year) +3.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
89.50 +3.51%
on 03/08/19
94.20 -1.66%
on 03/15/19
-0.16 (-0.17%)
since 02/20/19
3-Month
81.66 +13.45%
on 01/08/19
94.59 -2.06%
on 02/19/19
+2.74 (+3.05%)
since 12/20/18
52-Week
76.41 +21.24%
on 03/23/18
100.15 -7.50%
on 09/26/18
+12.74 (+15.94%)
since 03/20/18

Most Recent Stories

More News
Why the FDA Commissioner Pushed to Shorten Medical Device Approval Process

We all know the FDA is the arm of the U.S. government that, among other things, controls and oversees the approval process for medical device products and technologies are used in the diagnosis, prevention...

PDLI : 3.68 (+1.38%)
PBYI : 39.65 (-1.22%)
INNT : 2.20 (-0.90%)
MDT : 92.64 (-0.02%)
SOLY : 7.30 (+17.55%)
Diassess Inc. Announces Erik T. Engelson Joins as President & Chief Executive Officer

Diassess Inc., a developer of rapid, accurate, point-of-care infectious disease tests, announced today that Mr. Engelson has joined as President & Chief Executive Officer effective February...

MDT : 92.64 (-0.02%)
CSII : 39.41 (-0.13%)
FLDM : 14.35 (+3.91%)
SmarTrend Watching for Potential Rebound in Shares of Medtronic Plc After 2.44% Loss

Medtronic Plc (NYSE:MDT) traded in a range yesterday that spanned from a low of $91.50 to a high of $94.05. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $92.44...

MDT : 92.64 (-0.02%)
Look for Shares of Medtronic Plc to Potentially Rebound after Yesterday's 2.44% Sell Off

Medtronic Plc (NYSE:MDT) traded in a range yesterday that spanned from a low of $91.50 to a high of $94.05. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $92.44...

MDT : 92.64 (-0.02%)
New Clinical Trial Shows Medtronic TYRX(TM) Envelope Signficantly Reduces Major Infections in Cardiac Implantable Device Patients

Late-Breaking Trial Results Presented at European Heart Rhythm Association Annual Congress, ACC Scientific Sessions, and Published in The New England Journal of Medicine

MDT : 92.64 (-0.02%)
New Clinical Trial Shows Medtronic TYRX(TM) Envelope Signficantly Reduces Major Infections in Cardiac Implantable Device Patients

Late-Breaking Trial Results Presented at ACC Scientific Sessions and

MDT : 92.64 (-0.02%)
Medtronic Evolut Low Risk Trial Meets Primary Endpont

Less Invasive Evolut(TM) Transcatheter Aortic Valve Replacement (TAVR) System Successful in Clinical Trial When Compared to Open Heart Surgery in Healthier Aortic Stenosis Patients

MDT : 92.64 (-0.02%)
NASDAQ, S&P Recover Last Week’s Losses... and Then Some!

NASDAQ, S&P Recover Last Week’s Losses... and Then Some!

APYX : 7.81 (+1.56%)
CI : 172.78 (+3.39%)
CLDR : 11.87 (+0.17%)
ATVI : 46.55 (+0.28%)
DRI : 110.37 (-0.65%)
APPF : 74.34 (+0.72%)
MDT : 92.64 (-0.02%)
HD : 184.53 (+0.22%)
Global Vital Sign Monitoring Market Outlook, 2019 to 2024 with A&D Medical, Hill-Rom, Nihon Kohden, Koninklijke Philips, and Medtronic Dominating

The "Vital Sign Monitoring Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

MDT : 92.64 (-0.02%)
NHNKY : 15.9450 (-0.65%)
Global $26.43 Bn Medical Digital Imaging Systems Markets 2014-2019 & 2025 - Key Players are Siemens, Hitachi, GE, Koninklijke Philips, Canon Medical Systems, Hologic, Medtronic, and Shimadzu

The "Medical Digital Imaging Systems Market Size, Share & Trends Analysis Report By Type (X-ray, MRI, Ultrasound, CT, Nuclear Imaging), By Technology (2D, 3D/4D), By Region, And Segment Forecasts,...

HOLX : 47.43 (+0.53%)
MDSY : 0.73 (+4.29%)
MDT : 92.64 (-0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade MDT with:

Business Summary

Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders...

See More

Key Turning Points

2nd Resistance Point 93.78
1st Resistance Point 93.22
Last Price 92.64
1st Support Level 91.76
2nd Support Level 90.86

See More

52-Week High 100.15
Last Price 92.64
Fibonacci 61.8% 91.08
Fibonacci 50% 88.28
Fibonacci 38.2% 85.48
52-Week Low 76.41

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar